Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2010
08/05/2010US20100196421 clostridial neurotoxin propeptide which has a light chain region, a heavy chain region, where the light and heavy chain regions are linked by a disulfide bond, and an intermediate region connecting the light and heavy chain regions; intermediate region has a highly specific protease cleavage site
08/05/2010US20100196420 Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circulating in north american dogs
08/05/2010US20100196419 Enhancement of glycoprotein incorporation into virus-like particles
08/05/2010US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS
08/05/2010US20100196417 Compositions comprising a b subunit of shiga toxin and a means stimulating nkt cells
08/05/2010US20100196416 Vaccine
08/05/2010US20100196412 Homogeneous vaccine composition for the tumor treatment and its obtaining method
08/05/2010US20100196411 Yeast-Based Vaccine for Inducing an Immune Response
08/05/2010US20100196410 Streptococcus pneumoniae Antigens and Vaccines
08/05/2010US20100196409 Basb006 polypeptides from neisseria meningitidis and immunogenic compositions thereof
08/05/2010US20100196408 Metastatic colorectal cancer vaccine
08/05/2010US20100196407 Tick galectin
08/05/2010US20100196406 Agents for the treatment of inflammatory diseases and methods of using same
08/05/2010US20100196405 GLP-1 Fc FUSION PROTEIN FORMULATION
08/05/2010US20100196404 Methods of use of the taci/taci-l interaction
08/05/2010US20100196403 Antibody conjugates for circumventing multi-drug resistance
08/05/2010US20100196402 Method for Predicting the Response of a Patient to Treatment with an Anti-TNF Alpha Antibody
08/05/2010US20100196401 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
08/05/2010US20100196400 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof
08/05/2010US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
08/05/2010US20100196398 Targeted binding agents directed to cd105 and uses thereof
08/05/2010US20100196397 Five-helix protein
08/05/2010US20100196396 Compositions and methods for modulating ghrelin-mediated conditions
08/05/2010US20100196395 Anti-igf antibodies
08/05/2010US20100196394 Anti-cancer vaccine composition
08/05/2010US20100196393 Modulation of blood brain barrier protein expression
08/05/2010US20100196392 Anti-system asc amino acid transporter 2 (asct2) antibody
08/05/2010US20100196391 Shigella ipad protein and its use as a vaccine against shigella infection
08/05/2010US20100196390 Agonist anti-trkb monoclonal antibodies
08/05/2010US20100196389 Methods of using corticotropin-releasing factor for the use of the treatment of cancer
08/05/2010US20100196388 Targeted binding agents directed to sonic hedgehog homolog and uses thereof
08/05/2010US20100196387 Disulfide, Sulfide, Sulfoxide, and Sulfone Derivatives of Cyclic Sugars and Uses Thereof
08/05/2010US20100196386 Ligands of hvem for treating hematologic malignancies and autoimmune diseases
08/05/2010US20100196385 Targeted binding agents directed to dll4 and uses thereof 524
08/05/2010US20100196384 Anti-histone h1 monoclonal antibody and hybridoma for the production thereof
08/05/2010US20100196383 Connective Tissue Growth Factor (CTGF-3)
08/05/2010US20100196382 Nontypeable Haemophilus Influenzae Virulence Factors
08/05/2010US20100196381 P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
08/05/2010US20100196380 Babesia Subtilisin
08/05/2010US20100196379 Group B Streptococcus Polypeptides Nucleic Acids and Therapeutic Compositions and Vaccines Thereof
08/05/2010US20100196378 Removal promoters and inhibitor for apoptosis cells in vivo
08/05/2010US20100196377 Methods of treating, diagnosing or detecting cancer
08/05/2010US20100196376 Method for reducing allergen-induced airway hyperresponsiveness
08/05/2010US20100196374 Methods and compositions for treating autoimmune disease
08/05/2010US20100196373 native staphylococcal enterotoxin or streptococcal pyrogenic exotoxin protein, stimulates T cell mitogensis; fusion proteins; carcinomas; combination therapy
08/05/2010US20100196372 FcgammaRIIB Fusion Proteins and Compositions Thereof
08/05/2010US20100196371 Method of modulating the activity of functional immune molecules
08/05/2010US20100196370 Fusion protein of immunoglobulin fc and human apolipoprotein(a) kringle fragment
08/05/2010US20100196369 Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
08/05/2010US20100196368 Substituted benz-azoles and methods of their use as inhibitors of raf kinase
08/05/2010US20100196367 Methods For Screening Candidate Agents For Modulating Prorenin And Renin, Assays for Detecting Prorenin And Antibodies
08/05/2010US20100196366 Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related Thereto
08/05/2010US20100196365 Use of imidazoquinolines for the treatment of egfr dependent diseases or diseases that have acquired resistance to agents that target egfr family members
08/05/2010US20100196364 Monoclonal antibodies to fibroblast growth factor receptor 2
08/05/2010US20100196363 Cancer treatment combination therapy comprising vinflunine and trastuzumab
08/05/2010US20100196362 Engineering Fc Antibody Regions to Confer Effector Function
08/05/2010US20100196361 Method of inhibition of vascular development using an antibody
08/05/2010US20100196360 Neutrokine-alpha and neutrokine-alpha splice variant
08/05/2010US20100196359 Human Monoclonal Antibody Human CD134 (Ox40) and Methods of Making and Using Same
08/05/2010US20100196358 Method and kit to profile tumors by biomarker analyses including transcriptional factor assays
08/05/2010US20100196357 Microrna modulators and method for identifying and using the same
08/05/2010US20100196356 Tumour Growth Inhibitory Compounds and Methods of their Use
08/05/2010US20100196355 Immunophilin Ligands and Methods for Modulating Immunophilin and Calcium Channel Activity
08/05/2010US20100196354 Glutamate receptor antagonists and methods of use
08/05/2010US20100196353 Intradermal hpv peptide vaccination
08/05/2010US20100196352 Composition for increasing stamina
08/05/2010US20100196351 Secreted pate-like proteins
08/05/2010US20100196350 Pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma
08/05/2010US20100196349 Reeler domain containing protein
08/05/2010US20100196319 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
08/05/2010US20100196318 Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
08/05/2010US20100196317 Cyclic undecapeptides and derivatives as multiple sclerosis therapies
08/05/2010US20100196315 IL-12/p40 BINDING PROTEINS
08/05/2010US20100196311 METHODS AND COMPOSITIONS CONTAINING mTOR INHIBITORS FOR ENHANCING IMMUNE RESPONSES
08/05/2010US20100196280 Functionalized solid polymer nanoparticles for diagnostic and therapeutic applications
08/05/2010US20100196277 Nanoparticle compositions for controlled delivery of nucleic acids
08/05/2010US20100196267 Humanized L243 Antibodies
08/05/2010US20100196266 Humanized Anti-HLA-DR Antibodies
08/05/2010US20100196265 Anti-egfr family antibodies, bispecific anti-egfr family antibodies and methods of use thereof
08/05/2010CA2787697A1 Compositions comprising chlamydia antigens
08/05/2010CA2751261A1 Methods for pancreatic tissue regeneration
08/05/2010CA2750952A1 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
08/05/2010CA2750928A1 Methods of diagnosing and treating neurodegenerative diseases
08/05/2010CA2750922A1 Li-key hybrid peptides that modulate the immune response to influenza
08/05/2010CA2750649A1 Cobalamin taxane bioconjugates for treating eye disease
08/05/2010CA2750499A1 Novel synthetic agonists of tlr9
08/05/2010CA2749966A1 Il-1 binding proteins
08/05/2010CA2749947A1 Methods for treating estrogen receptor positive cancer by x-box binding protein 1 inhibition
08/05/2010CA2749325A1 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
08/05/2010CA2749200A1 Human anti-il-6 antibodies with extended in vivo half-life and their use in treatment of oncology, autoimmune diseases and inflammatory diseases
08/04/2010EP2213752A1 Recombinant Newcastle disease virus RNA expression systems and vaccines
08/04/2010EP2213746A1 Cell for use in the production of exogenous protein, and production process using the cell
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213742A1 Chimeric antigens for breaking host tolerance to foreign antigens
08/04/2010EP2213740A1 Human telomerase catalytic subunit
08/04/2010EP2213735A1 Peptide imparting antibody-binding ability to liposome and liposome modified with the same
08/04/2010EP2213685A1 Therapeutic anti-IL-1R1 monoclonal antibody
08/04/2010EP2213683A1 Variant Fc regions
08/04/2010EP2213673A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative
08/04/2010EP2213302A2 DR4 antibodies and uses thereof
1 ... 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 ... 1823